These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37153722)

  • 41. Blood eosinophil count as a predictor of hospital length of stay in COPD exacerbations.
    Ko FWS; Chan KP; Ngai J; Ng SS; Yip WH; Ip A; Chan TO; Hui DSC
    Respirology; 2020 Mar; 25(3):259-266. PubMed ID: 31385389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation.
    Chen TT; Lee KY; Chang JH; Chung CL; Tran HM; Manullang A; Ho SC; Chen KY; Tseng CH; Wu SM; Chuang HC
    Ann Med; 2023; 55(2):2285924. PubMed ID: 38065676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
    Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD.
    Russell R; Beer S; Pavord ID; Pullinger R; Bafadhel M
    Int J Chron Obstruct Pulmon Dis; 2019; 14():971-977. PubMed ID: 31190783
    [No Abstract]   [Full Text] [Related]  

  • 45. [Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD].
    Xue J; Cui YN; Chen P; Cai S; Chen L; Dai ZS; Chen Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):426-431. PubMed ID: 31189228
    [No Abstract]   [Full Text] [Related]  

  • 46. [Establishment and verification of risk prediction model of acute exacerbation of chronic obstructive pulmonary disease based on regression analysis].
    Wang M; Cai K; Shi D; Tu X; Zhao H; Li S; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jan; 33(1):64-68. PubMed ID: 33565403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical value of IL-13 and ECP in the serum and sputum of eosinophilic AECOPD patients.
    Li T; Gao L; Ma HX; Wei YY; Liu YH; Qin KR; Wang WT; Wang HL; Pang M
    Exp Biol Med (Maywood); 2020 Aug; 245(14):1290-1298. PubMed ID: 32493123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.
    Acet-Öztürk NA; Dilektasli AG; Aydın-Güçlü Ö; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Uzaslan E
    Clin Respir J; 2022 Jan; 16(1):49-56. PubMed ID: 34626077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.
    Rothnie KJ; Müllerová H; Smeeth L; Quint JK
    Am J Respir Crit Care Med; 2018 Aug; 198(4):464-471. PubMed ID: 29474094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peripheral Blood Eosinophil as a Biomarker in Outcomes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Wu HX; Zhuo KQ; Cheng DY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():3003-3015. PubMed ID: 31920297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Using complete blood count, serum immunoglobulins G/A/M and complement C3/C4 levels to predict the risk of COPD acute exacerbation: 2-year follow-up in a single-center prospective cohort study.
    He S; Wu S; Chen T; Cao C
    Clin Exp Med; 2023 Dec; 23(8):5161-5176. PubMed ID: 37328656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease.
    Kwok WC; Chau CH; Tam TCC; Lam FM; Ho JCM
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1145-1153. PubMed ID: 37332837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
    COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort.
    Wang J; Chai J; Sun L; Zhao J; Chang C
    BMC Infect Dis; 2020 Aug; 20(1):610. PubMed ID: 32811432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes.
    Aksoy E; Karakurt Z; Gungor S; Ocakli B; Ozmen İ; Yildirim E; Tuncay E; Agca MC; Ciftaslan Goksenoglu N; Adigüzel N
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2721-2730. PubMed ID: 30233162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevalence and clinical characteristics of blood eosinophilia in patients with acute exacerbation of chronic obstructive pulmonary disease].
    Zeng QL; Wang XM; Li SN; Xiong B; Jian M; Huang G; Wu YQ; Wang XH; Li J; Wen FQ; Zhou H
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(40):3166-3170. PubMed ID: 29081164
    [No Abstract]   [Full Text] [Related]  

  • 58. Multicentre double-blind randomised controlled trial of systematic corticosteroid therapy in patients with acute exacerbations of chronic obstructive pulmonary disease admitted to hospital with higher eosinophil levels: the ECHO protocol.
    Liang L; Lin Y; Feng L; Shao S; Cao S; Rong H; Chu S; Xie W; Cai S; Wang J; Tong Z
    BMJ Open; 2023 May; 13(5):e066354. PubMed ID: 37247957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
    Siddiqui SH; Pavord ID; Barnes NC; Guasconi A; Lettis S; Pascoe S; Petruzzelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3669-3676. PubMed ID: 30464449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive Role of White Blood Cell Differential Count for the Development of Acute Exacerbation in Korean Chronic Obstructive Pulmonary Disease.
    Yoon EC; Koo SM; Park HY; Kim HC; Kim WJ; Kim KU; Jung KS; Yoo KH; Yoon HK; Yoon HY
    Int J Chron Obstruct Pulmon Dis; 2024; 19():17-31. PubMed ID: 38192972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.